Krebs Biochem

KREBSBIO03 May 2024

Pharmaceuticals

₹

-2.43 (-3.24%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Krebs Biochem

Krebs Biochem

Pharmaceuticals

KREBSBIO03 May 2024

₹

-2.43 (-3.24%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
11-Jan-2019	R	21:100 Rights Issue of Equity Shares Trading Members of the Exchange are hereby informed that, Krebs Biochemicals & Industries Ltd has fixed the Record date for the purpose of Rights Issue of Equity Shares. The transactions in the equity shares of the Company should be done on ex-rights basis with effect from the under mentioned date. COMPANY NAME & CODE Krebs Biochemicals & Industries Ltd. (524518) RECORD DATE 01/02/2019 PURPOSE Issue of 21 (Twenty One) equity shares of Rs.10/- each on rights basis for cash at premium of Rs.76/- per share for every 100 (Hundred) equity shares held. Ex-Right basis from Date & Sett. No. 31/01/2019 DR-211/2018-2019 Trading Members of the Exchange are requested to take note of it. (As Per NSE Notice Dated 14.01.2019)	01-Feb-2019	21:100
15-Apr-2024	BC	Resignation of Mr. Keyur Doshi as Company Secretary and Compliance Officer of the Company.	15-Apr-2024
19-Jan-2024	BC	KREBS BIOCHEMICALS & INDUSTRIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve Unaudited Financial Resul	12-Feb-2024
17-Jan-2024	BC	The Board of Directors of the Company in its meeting held today and on recommendation of Nomination and Remuneration Committee have considered and approved the appointment of Mr. Keyur Doshi (Members	17-Jan-2024
17-Jan-2024	BC	The Board of Directors of the Company in its meeting held today and on recommendation of Nomination and Remuneration Committee have considered and approved the appointment of Mr. Keyur Doshi (Members	17-Jan-2024
18-Oct-2023	BC	KREBS BIOCHEMICALS & INDUSTRIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve un-audited financial resu	08-Nov-2023

Record Date01 Jan'1900

Ex-Rights Date01 Jan'1900

Premium(Rs.)76

Ratio21:100

Book Closure

Record Date	Split Date	Purpose
15-Apr-2024	-	Resignation of Mr. Keyur Doshi as Company Secretary and Compliance Officer of the Company.
12-Feb-2024	-	KREBS BIOCHEMICALS & INDUSTRIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve Unaudited Financial Resul
17-Jan-2024	-	The Board of Directors of the Company in its meeting held today and on recommendation of Nomination and Remuneration Committee have considered and approved the appointment of Mr. Keyur Doshi (Members
17-Jan-2024	-	The Board of Directors of the Company in its meeting held today and on recommendation of Nomination and Remuneration Committee have considered and approved the appointment of Mr. Keyur Doshi (Members
08-Nov-2023	-	KREBS BIOCHEMICALS & INDUSTRIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve un-audited financial resu

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Krebs Biochemicals & Industries Ltd ₹72.58(-2.43/-3.24%)	72.58	-2.43	156.49	5.19	0.00	-1.44
Astrazeneca Pharma India Ltd ₹5,424.45(+90.60/1.70%)	5,424.45	+90.60	13,561.13	71.45	85.02	20.71
Bliss GVS Pharma Ltd ₹119.10(-10.10/-7.82%)	119.10	-10.10	1,246.87	56.07	18.27	1.28
Cipla Ltd ₹1,424.75(+5.20/0.37%)	1,424.75	+5.20	115,033.60	54.70	34.98	4.44
Amrutanjan Health Care Ltd ₹775.50(-11.10/-1.41%)	775.50	-11.10	2,242.02	27.78	50.95	8.56
Abbott India Ltd ₹26,144.45(-459.90/-1.73%)	26,144.45	-459.90	55,556.96	15.92	48.50	17.87

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	12.98	14.89	10.58	11.46	9.09	20.94
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	12.98	14.89	10.58	11.46	9.09	20.94
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.03	0.17	0.04	0.19	0.02	0.27
Total Income	13.01	15.06	10.62	11.65	9.11	21.22
Total Expenditure	15.07	15.79	13.20	16.08	12.08	22.84
PBIDT	-2.06	-0.73	-2.58	-4.43	-2.96	-1.63
Interest	1.19	1.13	1.10	1.03	0.90	0.74
PBDT	-3.25	-1.86	-3.68	-5.46	-3.86	-2.37
Depreciation	1.73	1.71	1.65	1.48	1.69	1.69
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-4.98	-3.57	-5.33	-6.94	-5.55	-4.06
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-4.98	-3.57	-5.33	-6.94	-5.55	-4.06

EPS (Unit Curr.)	-2.31	-1.66	-2.47	-3.07	-2.58	-1.88
EPS (Adj) (Unit Curr.)	-2.31	-1.66	-2.47	-3.07	-2.58	-1.88
Calculated EPS (Unit Curr.)	-2.31	-1.66	-2.47	-3.22	-2.58	-1.88
Calculated EPS (Adj) (Unit Curr.)	-2.31	-1.66	-2.47	-3.22	-2.58	-1.88
Calculated EPS (Ann.) (Unit Curr.)	-9.23	-6.63	-9.89	-12.87	-10.30	-7.53
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-9.23	-6.63	-9.89	-12.87	-10.30	-7.53
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	21.56	21.56	21.56	21.56	21.56	21.56
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-15.87	-4.90	-24.39	-38.66	-32.56	-7.78
PBDTM(%)	-25.04	-12.49	-34.78	-47.64	-42.46	-11.32
PATM(%)	-38.37	-23.98	-50.38	-60.56	-61.06	-19.39

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	151.56	151.56	49.62	48.00	16.63	13.74
Reserves Total	-121.02	-96.65	-66.52	-43.00	-30.92	-31.52
Equity Share Warrants	0.00	0.00	4.17	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	30.54	54.91	-12.73	5.00	-14.29	-17.78
Secured Loans	0.00	0.00	71.14	35.51	0.00	5.44
Unsecured Loans	53.37	13.10	10.00	0.71	53.38	50.77
Total Debt	53.37	13.10	81.14	36.22	53.38	56.21
Total Liabilities	83.91	68.01	68.41	41.22	39.09	38.43
APPLICATION OF FUNDS :
Gross Block	303.04	287.95	260.88	243.11	234.41	228.54
Less : Accumulated Depreciation	155.73	149.25	142.95	137.82	133.15	127.77
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	147.31	138.70	117.93	105.29	101.26	100.77
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	4.09	8.38	11.94	4.19	3.48	3.73
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	11.95	25.56	16.60	15.00	8.96	11.73
Sundry Debtors	0.53	0.88	0.30	0.20	2.91	0.32
Cash and Bank	0.09	0.10	0.71	0.17	17.32	0.42
Loans and Advances	3.50	8.95	3.81	3.49	1.78	4.77
Total Current Assets	16.06	35.49	21.42	18.86	30.98	17.24
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	37.72	66.73	36.11	40.44	50.28	36.48
Provisions	1.26	1.17	1.49	1.99	1.43	1.25
Total Current Liabilities	38.98	67.89	37.60	42.43	51.71	37.73
Net Current Assets	-22.92	-32.40	-16.18	-23.57	-20.73	-20.49
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	128.48	114.69	113.68	85.91	84.02	84.02
Contingent Liabilities	5.55	5.55	3.74	3.94	0.80	5.51

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.10	0.71	0.17	17.32	0.42
Net Cash from Operating Activities	-24.71	-17.22	-14.57	-35.50	3.90
Net Cash Used In Investing Activities	-12.65	-22.90	-22.55	-10.22	-4.32
Net Cash Used In Financing Activities	37.34	39.51	37.66	28.58	17.32
Net Inc./Dec In Cash And Cash Equivalents	-0.01	-0.61	0.54	-17.14	16.90
Cash And Cash Equivalents At End Of The Year	0.09	0.10	0.71	0.17	17.32

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

72.74%

FII Shareholding

0.49%

DII Shareholding

0.00%

Public Shareholding

26.76%

**Promoter pledged shareholding 72.74%

About Krebs Biochemicals & Industries Ltd

Krebs Biochemicals & Industries Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 156.49 crores. It has reported a sales of Rs. 12.98 crores and a net profit of Rs. -4.98 crores for the quarter ended December 2018. The company management includes R T Ravi, G V L Prasad,R T Ravi,Avinash Ravi,Tangirala Malati,Satish Khivsara,Raj Kamal Prasad Verma,Rohit Taparia,Jitendra Shah (Krebs Biochemicals & Industries Ltd) among others.

Chairman

R T Ravi

Registered office

Kothapalli(V) Kasimkota(M),Anakapalli,Vishakapatnam,Andhra Pradesh,531031

FAX :

Background

Incorporation Year1991

Face Value₹10

Market Lot1

How to buy Krebs Biochem shares on nse?

To buy Krebs Biochem shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Krebs Biochem share price today?

The Krebs Biochem shares price on nse is Rs.72.58 today.

What is the market cap of Krebs Biochem shares on BSE ?

The company has a market capitalization of Rs.156.49Cr

What is the PE & PB ratio of Krebs Biochem shares ?

PE is 0 and PB is -1.44

What is the 52 Week High and Low of Krebs Biochem shares?

Krebs Biochem stock price high: Rs.93.2 Krebs Biochem stock price low: Rs.59.3